Literature DB >> 17262706

Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection.

Gathsaurie Neelika Malavige1, Louise Jones, Antony Paul Black, Graham Stuart Ogg.   

Abstract

Glycoprotein I (gI) of varicella-zoster virus (VZV) contributes to viral virulence and is therefore a potentially important target for T cell control of viral replication. Persisting effector function of gI-specific T cells after primary infection has not been previously examined. We have shown that, many decades after infection, relatively high frequencies gI-specific interferon- gamma responses are detectable ex vivo and are dominated by CD4(+) T cells. We characterized the optimal peptide of the strongest response in our cohort showing restriction through DRB4*01. These findings are consistent with gI-specific CD4(+) T cell involvement in the control of VZV replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17262706     DOI: 10.1086/511274

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

2.  Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.

Authors:  Adriana Weinberg; Jennifer Canniff; Nadine Rouphael; Aneesh Mehta; Mark Mulligan; Jennifer A Whitaker; Myron J Levin
Journal:  J Immunol       Date:  2017-06-12       Impact factor: 5.422

3.  Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.

Authors:  G N Malavige; L Jones; A P Black; G S Ogg
Journal:  Clin Exp Immunol       Date:  2008-03-20       Impact factor: 4.330

4.  Genome-wide analysis of T cell responses during acute and latent simian varicella virus infections in rhesus macaques.

Authors:  Kristen Haberthur; Aubrey Kraft; Nicole Arnold; Byung Park; Christine Meyer; Mark Asquith; Jesse Dewane; Ilhem Messaoudi
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

5.  Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells.

Authors:  Miyuki Tanaka; Haruko Tashiro; Bilal Omer; Natasha Lapteva; Jun Ando; Minhtran Ngo; Birju Mehta; Gianpietro Dotti; Paul R Kinchington; Ann M Leen; Claudia Rossig; Cliona M Rooney
Journal:  Clin Cancer Res       Date:  2017-02-09       Impact factor: 12.531

6.  Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans.

Authors:  Ilhem Messaoudi; Alexander Barron; Mary Wellish; Flora Engelmann; Alfred Legasse; Shannon Planer; Don Gilden; Janko Nikolich-Zugich; Ravi Mahalingam
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

7.  IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.

Authors:  G N Malavige; L T Rohanachandra; L Jones; L Crack; M Perera; N Fernando; D Guruge; G S Ogg
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

8.  Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.

Authors:  Lichen Jing; Kerry J Laing; Lichun Dong; Ronnie M Russell; Russell S Barlow; Juergen G Haas; Meena S Ramchandani; Christine Johnston; Soren Buus; Alec J Redwood; Katie D White; Simon A Mallal; Elizabeth J Phillips; Christine M Posavad; Anna Wald; David M Koelle
Journal:  J Immunol       Date:  2016-01-25       Impact factor: 5.422

Review 9.  Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.

Authors:  Jianmin Zuo; Martin Rowe
Journal:  Viruses       Date:  2012-08-22       Impact factor: 5.048

10.  Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus Vaccine.

Authors:  Tamar A Smith-Norowitz; Joby Josekutty; Jonathan I Silverberg; Hadar Lev-Tov; Yitzchok M Norowitz; Stephan Kohlhoff; Maja Nowakowski; Helen G Durkin; Martin H Bluth
Journal:  Int J Biomed Sci       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.